Fairmount Funds Management LLC

Q3 2025 13F Holdings

  • Location
    west conshohocken, PA
  • Num holdings

    17

  • Value ($000)

    $1,111,423

  • Date Filed
    11/14/2025
  • Form type
    13F-HR
  • CIK
    0001802528
  • All SEC filings
  • Note
    Holdings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q3 2025 to
Select Quarter
Issuer Name
Class
CUSIP
VALUE
%
Shares
Principal
Option Type
D
DNTH

DIANTHUS THERAPEUTICS INC

COM
252828108
$130.14M
12 %

3,307,191

C
COGT

COGENT BIOSCIENCES INC

COM
19240Q201
$129.29M
12 %

9,003,418

A
AXSM

AXSOME THERAPEUTICS INC

COM
05464T104
$99.00M
9 %

815,176

A
APGE

APOGEE THERAPEUTICS INC

COM
03770N101
$81.39M
7 %

2,048,647

E
ELVN

ENLIVEN THERAPEUTICS INC

COM
29337E102
$75.97M
7 %

3,711,444

V
VRDN

VIRIDIAN THERAPEUTICS INC

COM
92790C104
$74.66M
7 %

3,459,913

---

ORUKA THERAPEUTICS INC

COM
687604108
$71.25M
6 %

3,705,262

---

KINIKSA PHARMACEUTICALS INTL

ORD SHS CL A
G52694109
$68.84M
6 %

1,772,839

S
SRRK

SCHOLAR ROCK HLDG CORP

COM
80706P103
$67.93M
6 %

1,824,031

S
SYRE

SPYRE THERAPEUTICS INC

COM NEW
00773J202
$67.34M
6 %

4,018,101

Rows Per Page
10
  • 10
  • 50
  • 100
1 - 10 of 17